DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.

Bazan, V

DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. [electronic resource] - Journal of cancer research and clinical oncology Dec 2002 - 650-8 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0171-5216

10.1007/s00432-002-0394-6 doi


Adenocarcinoma--genetics
Adenocarcinoma, Mucinous--genetics
Biomarkers, Tumor--analysis
Cell Division
Colon--pathology
Colorectal Neoplasms--genetics
DNA, Neoplasm--genetics
Disease-Free Survival
Humans
Immunohistochemistry
Lymph Nodes--pathology
Monomeric GTP-Binding Proteins--genetics
NM23 Nucleoside Diphosphate Kinases
Neoplasm Staging
Nucleoside-Diphosphate Kinase
Ploidies
Predictive Value of Tests
S Phase
Survival Analysis
Time Factors
Transcription Factors--genetics
Treatment Outcome
Tumor Suppressor Protein p53--genetics